These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 187020)
41. Development of non-toxigenic vaccine strains of Bordetella pertussis by gene replacement. Cockle S; Zealey G; Loosmore S; Yacoob R; Fahim R; Yang YP; Jackson G; Boux H; Boux L; Klein M Adv Exp Med Biol; 1991; 303():221-5. PubMed ID: 1805567 [No Abstract] [Full Text] [Related]
42. Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels. Ashworth LA; Fitzgeorge RB; Irons LI; Morgan CP; Robinson A J Hyg (Lond); 1982 Jun; 88(3):475-86. PubMed ID: 6282959 [TBL] [Abstract][Full Text] [Related]
43. Immunization of pigs against Bordetella bronchiseptica infection by parenteral vaccination. Harris DL; Switzer WP Am J Vet Res; 1972 Oct; 33(10):1975-84. PubMed ID: 4342331 [No Abstract] [Full Text] [Related]
44. The influence of the ventral posterior hypothalamus on Bordetella pertussis vaccine-induced eosinophilia. TJABBES T; de WIED Arch Int Pharmacodyn Ther; 1962 Jan; 135():218-22. PubMed ID: 13921428 [No Abstract] [Full Text] [Related]
45. Crossed immunoelectrophoretic analysis of Bordetella pertussis antigens and of corresponding antibodies in human sera. Hertz JB; Hølby N; Andersen V; Baekgaard P Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):386-94. PubMed ID: 187009 [TBL] [Abstract][Full Text] [Related]
46. [Immunobiological properties of Bordetella pertussis]. Kopacka B Pediatr Pol; 1972; 47(3):361-70. PubMed ID: 4336329 [No Abstract] [Full Text] [Related]
47. A causal relationship between Bordetella pertussis and Bordetella parapertussis infections. Kawai H; Aoyama T; Murase Y; Tamura C; Imaizumi A Scand J Infect Dis; 1996; 28(4):377-81. PubMed ID: 8893402 [TBL] [Abstract][Full Text] [Related]
48. Further contributions to an improved pertussis vaccine: II. New findings in the development of a pertussis vaccine. Robbel L; Hungerer KD; Aktories K Behring Inst Mitt; 1984 Nov; (76):110-2. PubMed ID: 6098261 [No Abstract] [Full Text] [Related]
49. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model. Komatsu E; Yamaguchi F; Eguchi M; Watanabe M Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876 [TBL] [Abstract][Full Text] [Related]
50. A Functional Tricarboxylic Acid Cycle Operates during Growth of Bordetella pertussis on Amino Acid Mixtures as Sole Carbon Substrates. Izac M; Garnier D; Speck D; Lindley ND PLoS One; 2015; 10(12):e0145251. PubMed ID: 26684737 [TBL] [Abstract][Full Text] [Related]
51. Recombinant Bordetella pertussis pertactin (P69) from the yeast Pichia pastoris: high-level production and immunological properties. Romanos MA; Clare JJ; Beesley KM; Rayment FB; Ballantine SP; Makoff AJ; Dougan G; Fairweather NF; Charles IG Vaccine; 1991 Dec; 9(12):901-6. PubMed ID: 1811375 [TBL] [Abstract][Full Text] [Related]
52. Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate. Dounighi NM; Shahcheraghi F; Razzaghi-Abyaneh M; Nofeli M; Zolfagharian H Curr Pharm Biotechnol; 2017; 18(7):585-593. PubMed ID: 28814229 [TBL] [Abstract][Full Text] [Related]
53. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines. Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807 [TBL] [Abstract][Full Text] [Related]
54. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R Vaccine; 2015 Nov; 33(46):6277-81. PubMed ID: 26432908 [TBL] [Abstract][Full Text] [Related]
55. Sensitization to ragweed pollen in Bordetella pertussis-infected or vaccine-injected mice. Chang IC; Gottshall RY J Allergy Clin Immunol; 1974 Jul; 54(1):20-4. PubMed ID: 4365297 [No Abstract] [Full Text] [Related]
57. Gene-expression-based quality scores indicate optimal harvest point in Bordetella pertussis cultivation for vaccine production. van de Waterbeemd B; Streefland M; Pennings J; van der Pol L; Beuvery C; Tramper J; Martens D Biotechnol Bioeng; 2009 Aug; 103(5):900-8. PubMed ID: 19405154 [TBL] [Abstract][Full Text] [Related]
58. [A comparative analysis of the effect of Bordetella pertussis preparations on a primary culture of murine peritoneal macrophages]. Tiukavkina SIu; Moskalenko EP Mikrobiol Z; 1996; 58(2):58-63. PubMed ID: 8983523 [TBL] [Abstract][Full Text] [Related]
59. [The presence of a substance complementary to the agglutinogen of B. pertussis in the serum of normal mice]. Kuznetsov EA Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):81-4. PubMed ID: 4337416 [No Abstract] [Full Text] [Related]
60. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis. Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]